Epidermal Growth Factor Receptor Family and Chemosensitization
Open Access
- 5 March 1997
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 89 (5), 341-343
- https://doi.org/10.1093/jnci/89.5.341
Abstract
Alteration in the expression and activation of protein tyrosine kinases and cell cycle regulatory genes not only can lead directly to the perturbation of growth regulation but also may affect the sensitivity of cancer cells to conventional chemotherapy and radiation therapy. In recent years, numerous studies have explored the effects on chemosensitivity resulting from altered expression and activation of the epidermal growth factor (EGF) receptor and the HER-2/neu receptor.Keywords
This publication has 20 references indexed in Scilit:
- Abrogation of Cisplatin-Induced Programmed Cell Death in Human Breast Cancer Cells by Epidermal Growth Factor Antisense RNAJNCI Journal of the National Cancer Institute, 1997
- Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.Journal of Clinical Oncology, 1996
- Increased resistance to cytotoxic agents in ZR75B human breast cancer cells transfected with epidermal growth factor receptorMolecular and Cellular Endocrinology, 1995
- Increased epidermal growth factor receptor in an estrogen‐responsive, adriamycin‐resistant MCF‐7 cell lineJournal of Cellular Physiology, 1993
- Antitumor Effects of Doxorubicin in Combination With Anti-epidermal Growth Factor Receptor Monoclonal AntibodiesJNCI Journal of the National Cancer Institute, 1993
- Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.Journal of Clinical Oncology, 1992
- Phase I and Imaging Trial of Indium 111-Labeled Anti-Epidermal Growth Factor Receptor Monoclonal Antibody 225 in Patients With Squamous Cell Lung CarcinomaJNCI Journal of the National Cancer Institute, 1991
- Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatin.Journal of Clinical Investigation, 1990
- Efficacy of Antibodies to Epidermal Growth Factor Receptor Against KB Carcinoma In Vitro and in Nude MiceJNCI Journal of the National Cancer Institute, 1988
- A Multidrug-Resistant MCF-7 Human Breast Cancer Cell Line Which Exhibits Cross-Resistance to Antiestrogens and Hormone-Independent Tumor Growthin VivoMolecular Endocrinology, 1988